Biomarkers for preterm births using non-invasive samples

Go Back to All Clinical Trials

Biomarkers for preterm births using non-invasive samples

Brief description of study

The purpose of this study is to evaluate if biomarkers measured in body fluids (such as saliva, urine, vaginal fluid, and blood) in pregnant women presenting with symptoms of preterm labor (such as uterine contractions) will predict progression to actual preterm delivery (birth of the baby). Biomarkers are a measurable substance in body fluid that can predict that occurrence of a specific outcome, in this case, it will be preterm birth. The study will compare inflammatory biomarkers from non-invasive samples (blood, urine and saliva) in pregnant women presenting with preterm labor with rapid progression to delivery (3 days or less) compared to pregnant women presenting with preterm labor who deliver more than 3 days from preterm labor.

Clinical Study Identifier: s19-01327

Principal Investigator: Nazeeh N Hanna.

Other Investigators: Ashley S Roman, Martin Chavez.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies